NCT06159504 - Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania | Biotech Hunter

Enrollment

3,040

Participants

Timeline

Start Date

October 3, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Hepatitis CRDT

Interventions

DRUG

sofosbuvir/velpatasvir (SOF/VEL)

400mg of SOF and 100mg of VEL self administered daily as a tablet.

DIAGNOSTIC_TEST

Shortened read time of rapid diagnostic test for hepatitis C virus.

Administered once during hepatitis C testing. Test is read after 5 minutes rather than its usual time of 20 minutes.

Trial Locations (1)

RECRUITING

National Institute for Infectious Diseases, Yerevan